Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9Lung Neoplasms 3Uterine Cervical Neoplasms 2Neoplasms 2Motor Activity 2Colorectal Neoplasms 2Anxiety Disorders 2Sarcopenia 1Resectable Lung Non-Small Cell Carcinoma 1Psychological Well-Being 1Prostatic Neoplasms 1Postoperative Complications 1Parasomnias 1Panic Disorder 1Pancreatic Neoplasms 1Liver Neoplasms 1Fatigue 1Emotional Regulation 1Depression 1Colonic Neoplasms 1Caregivers With a Child Followed up With a Cancer Diagnosis 1Bile Duct Neoplasms 1

Interventions

Sorafenib 68Bevacizumab 44Oxaliplatin 25Doxorubicin 22Gemcitabine 21Fluorouracil 21Radiosurgery 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17lenvatinib 17Cisplatin 17Capecitabine 17atezolizumab 14Leucovorin 14Hepatectomy 14Radiotherapy 12tremelimumab 10Irinotecan 10Drug Therapy 10Cyclophosphamide 10Carboplatin 10Blood Specimen Collection 10Ipilimumab 9regorafenib 8Liver Transplantation 8Everolimus 8Cryosurgery 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Relaxation Therapy × Clear all
NCT03475966 2020-12-08

Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Unknown
60 enrolled
Gastrointestinal

Bile Duct Neoplasms, Liver Neoplasms, Motor Activity, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡